Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section...
-
Upload
shanon-bradford -
Category
Documents
-
view
215 -
download
3
Transcript of Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section...
![Page 1: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/1.jpg)
Stem Cells and Cancer
Donald Vander Griend, Ph.D.Assistant Professor
Department of Surgery, Section of Urology
![Page 2: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/2.jpg)
Today…
• Pluripotency and Stem Cells
• Tumor Initiating Cells (TICs)
• Cancer Stem Cells (CSCs)
• Stem Cell-Derived Cancers
![Page 3: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/3.jpg)
Stem Cell Potency• Totipotent: can generate the whole organism
including extra-embryonic tissues. Only the zygote and early blastomere are totipotent.
• Pluripotent: can generate the whole organism but not the extra-embryonic tissues. ES cells are pluripotent.
• Multipotent: can give rise to all cell types within one particular lineage. HSCs are multipotent.
• Unipotent: only form one cell type. Spermatogonial stem cells are unipotent.
![Page 4: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/4.jpg)
What defines Pluripotency?
• Pluripotency describes a cell’s ability to give rise to all of the cells of an embryo and adult.
• Recently, there has been an ongoing debate about what molecularly defines “pluripotency” of ES cells
![Page 5: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/5.jpg)
Measuring Pluripotent Potential
1. In vitro differentiation: differentiation induced in cell culture and cells are assayed for the expression of cell-type specific markers. Limitation: marker expression is no test for functionality.
2. Teratoma formation: induction of tumors demonstrating the potential to generate differentiated cell lineages. Limitation: does not test within normal development, but most useful for human ES cells.
3. Chimera formation/Germline contribution: contribution of cells to normal development and generation of germ cells. Limitation: may not complement all cell types or over complement host defects.
4. Tetraploid complementation: injection of test cells into 4n blastocyst. Because 4n host cells cannot contribute to somatic lineages, embyro is exclusively composed of test cells.
![Page 6: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/6.jpg)
Teratomas: Stem Cell-Derived Tumors
•“Monstrous tumor”•Tumor tissue of embryonic origin that contains normal derivatives of all three germ layers.• Reported to contain hair, teeth, bone and even more complex organs such as eye, torso, hands, feet, and other limbs. Also may contain tissues resembling brain, thyroid, liver, and lung.•Can be derived from germ cells or embryonal cells.
![Page 7: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/7.jpg)
Pluripotent ES cells and Chimeras
Chimeric Mouse
![Page 8: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/8.jpg)
Can Somatic Cells be Reprogrammed?
![Page 9: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/9.jpg)
Takahashi and Yamanaka, Cell 2006
• “Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors.”
• ES-specific promoter (Fbx15) driving a beta-gal/NeoR fusion gene (geo). Expressed combinations of cDNAs and screened for ES cell colonies.
![Page 10: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/10.jpg)
Teratomas derived from Induced Pluripotent Stem Cells (iPSCs)
![Page 11: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/11.jpg)
Chimeras derived from iPSCs (Derived from Adult Tail Tip Fibroblasts)
GFP of Chimeras
GFP IHC of Embryonic Tissues
![Page 12: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/12.jpg)
Liver Cells from Adult Mouse
Oct3/4Sox2Klf-4c-Myc
iPS Cells
Chimeric Mousew/ Germline incorporation
Okita et al. Nature 2007
+
WT mouse
Control
Generated F1 and F2 progeny from iPS cells.
![Page 13: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/13.jpg)
Implications for Cancer
• 7-10 day transient expression of these four factors caused an adult hepatocyte to become reprogrammed to a pluripotent ES cell.
• Cells can definitely go backwards in their differentiation, including gene expression and methylation.
• Such a phenotype does not require a stable genetic or epigenetic event. Can be a “hit and run” transformation event.
• “Royal Flush” hypothesis
![Page 14: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/14.jpg)
“Stemness”
• Self-renewal: maintains a stable population of itself.
• Hierarchy: generates phenotypically distinct progeny and lineages.
• Durable: Enhanced mechanisms for survival and repair of damage.
• Environment: Stem cells are highly regulated by their niche.
• Asymmetric cell division (?)
![Page 15: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/15.jpg)
Stem Cell Division and Generation of Lineages
![Page 16: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/16.jpg)
The Immortal Strand Hypothesis
Rando TA vs. Lansdorp PM; Cell 129, 2007
![Page 17: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/17.jpg)
Stem Cells and Tissue Turnover
(Epithelial Glandular Tissue)
Stem NE Basal IntermediateLuminal/Secretory
Renewal Capacity:
Proliferation:
Glandular Secretions:
EpithelialCell Type:
Terminal Differentiati
on
![Page 18: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/18.jpg)
Differentiation: An Essential Concept in Stem Cell Biology
Definition: The overall process of progenitor cells activating genetic and epigenetic mechanisms to define the specialized characteristics of mature cells.
Characteristics:Less or loss of proliferative abilityLoss of self-renewal capabilityMoving towards tissue-specific biological function.
![Page 19: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/19.jpg)
The Tumor Initiating Cell
• Who Cares: Identifying the cell of origin for a type of cancer is a critical step in understanding carcinogenesis and disease prevention.
• Cancers behave differently depending on the cell of origin.
• Examples: – Breast Cancer: ER/PR/HER2 status. Triple-negative
“basal-like” tumors are the worst. Also have Luminal A vs. Luminal B vs. HER2+
– Lung Cancer: NSCLC (squamous, adenocarcinoma, large cell carcinoma) vs. SCLC (neuroendocrine).
![Page 20: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/20.jpg)
The significance of specific tumor suppressor gene mutations for determining the tumor initiating
cell?
• Loss of Rb predisposes to small cell lung carcinoma whereas p16 loss/silencing predisposes to non-small cell carcinoma
• Does this reflect differential roles of these genes in the respective stem cells of the lung, ie. neuroendocrine versus epithelial?
![Page 21: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/21.jpg)
Identifying the “Tumor Initiating” Cell. • Tumors are clonally derived from a single aberrant cell, the
“tumor initiating cell”.• Tissue stem cells are attractive candidate “tumor-initiating”
cells since they share with tumor cells the capacity for self-renewal and clonal expansion.
• Do tumorigenic mutations need to occur in stem cells in order to propagate the tumor on a long term basis?
• The turnover of cycling progenitors may be too rapid to allow them to accumulate all the required mutations to develop into a tumor”.
• Stem cells not subject to selection until they expand allowing them to acquire mutations while “resting”. Mutations in oncogenes/TSGs may not have severe phenotypic consequences for the non-proliferating stem cell pool but would be tumorigenic in the highly proliferative daughter cells.
• Are stem cells therefore a reservoir of oncogenic mutations?• If stem cells are the tumor-initiating cells for most cancers then
this may explain why therapies that target proliferating cells (tumor cells) fail to eliminate cancer on a long term basis since the mutant stem cell pool would survive and act as a reservoir of potential tumor cells.
![Page 22: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/22.jpg)
Limitless self-renewal propertiesQuiescent
Limited self-renewal propertiesHighly proliferative
TUMOR CELLSLimitless self-renewal properties
Highly proliferative
Do tumor arise clonally from “immortal” stem cells that acquire proliferative potential, or from highly proliferative progenitors that acquire self-renewal capacity?
![Page 23: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/23.jpg)
Stem cells acquire proliferative/survival potential and their expanded progenitor progeny then acquire self-renewal
potential.
![Page 24: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/24.jpg)
Cancer Stem Cells: Not A New Concept
• The concept that cancer might arise from a rare population of cells with stem cell properties was proposed about 150 years ago (German Papers).
• Over 40 years ago it was postulated that tissue-specific stem cells may be the cell of origin of cancer (Till et al., 1961).
• In 1971, Pierce et al. showed experimentally that cellular hierarchy existed in squamous cell carcinomas in vivo. They found that malignant undifferentiated cells gave rise to benign well-differentiated cells.
• Potter, in 1978, championed the concept of “oncology is blocked ontogeny” suggesting that a lack of differentiation plays a critical role in cancer.
![Page 25: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/25.jpg)
Identifying Cancer Stem Cells
Controversial “Stem” of Caution: the use of immunodeficient mice for transplantation may not accurately reflect what occurs in human cancers.- Nude- SCID- NOD-SCID- NOG-SCID
![Page 26: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/26.jpg)
Cancer Stem Cells vs. Clonal EvolutionCancer Stem
Cell ModelRare to Moderate
Heterogeneous
Hierarchical
Stable, epigenetic
Possible to target only
tumorigenic cells
Germ lineage tumors
Stochastic Clonal
Evolution Model
High
Heterogeneous or Homogeneous
Not hierarchical
Unstable, epigenetic or genetic
Target most or all cells
HG B Cell lymphoblastic
leukemia
• Frequency of cancer cells with tumorigenic potential
• Phenotype of cancer cells
• Tumor organization
• Intrinsic differences between tumorigenic and non-tumorigenic cells
• Rational approach to therapy
• Compelling clinical evidence
![Page 27: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/27.jpg)
High Frequency of Cancer Forming Ability (Stochastic
Model)
Kelly et al.; Science 2007
Quintana et al.; Nature 2008
![Page 28: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/28.jpg)
A Cancer Stem Cell ExampleO’Brien et al.; Nature 2007
CD133+ populations from patients with colon cancer, injected as xenografts into NOD-SCID mice
Questions:1.CD133+ cells more tumorigenic that CD133- cells (initiating cells)?2.Tumor xenograft from CD133+ cells resemble original tumor (subset)?3.CD133+ derived tumors contain CD133- populations (lineages)?4.Do CD133+ cells from tumors able to re-derive more tumors (self-renewal)?
![Page 29: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/29.jpg)
Clinical Relevance of CSCs
![Page 30: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/30.jpg)
Cancer Stem Cell Hypothesis
Treatment Relapse
Heterogeneous Tumor
More effective
gene specific
therapies will cure.
*
Relapse
Cancer Stem Cell Model More
effective anti-tumor therapies
will reduce but NOT
cure.Pursue
different target.
![Page 31: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/31.jpg)
Multiple Myeloma CSCs Exhibit Differential Sensitivity to Drugs
![Page 32: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/32.jpg)
Other Clinical Considerations
• Markers for early detection: detection of CSC populations vs. differentiated cells.
• Cancer Prevention: in some instances normal stem cell expansion is the first event in carcinogenesis (inflammation).
• Clinical Trials: short term vs. long term outcomes (survival). An agent that kills CSCs may have no measureable short-term benefit.
![Page 33: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/33.jpg)
Identifying Stem-Like Populations
![Page 34: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/34.jpg)
Sphere Formation
Surface Markers
![Page 35: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/35.jpg)
ABCG2: ATP-Binding Cassette Transporter Type
G2• Also called BCRP (Breast Cancer Resistance Protein)• Originally identified as being over-expressed in a
Multiple Drug Resistant (MDR) breast cancer cell line.• Implicated in the side population phenotype for stem
cells (SP).
Figure from A.H. Schinkel, J.W. Jonker / Advanced Drug Delivery Reviews 55 (2003) 3–29
P-Glycoprotein (ABCB1) BCRP (ABCG2) - Homodimerizes
Out Out
![Page 36: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/36.jpg)
Side Population to Identify ABCG2/BCRP+ Cells
![Page 37: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/37.jpg)
ALDH: Aldehyde Dehydrogenase
All trans retinal
All trans Retinoic acid
9-cis retinal
ALDH
9- cis Retinoic acid
RARs RARs and RXRs
Promoter RAREsPromoter RAREs
Vitamin A - retinol
All trans retinal
All trans Retinoic acid
9-cis retinal
ALDH
9- cis Retinoic acid
RARs RARs and RXRs
Promoter RAREsPromoter RAREs
Vitamin A - retinol
•12 ALDH genes in humans
•Oxidize a variety of aliphatic and aromatic aldehydes.
•General detoxifying enzymes
•ALDH1 is a cytosolic enzyme which is important in retinoic acid signaling.
Figure from Aldagen Talk; Michelle Fiordalisi, Ph.D.
![Page 38: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/38.jpg)
ALDEFLUOR: Overview
ALDH1Substrate
(weakly fluorescent)Product
(strongly fluorescent)DEAB
ALDH1+
ALDH1-
+
ALDH1+
ALDH1-
Bright
Dim
Cells
![Page 39: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/39.jpg)
ALDEFLUOR to Detect ALDH1 Activity
![Page 40: Stem Cells and Cancer Donald Vander Griend, Ph.D. Assistant Professor Department of Surgery, Section of Urology.](https://reader030.fdocuments.us/reader030/viewer/2022032802/56649e055503460f94af1b78/html5/thumbnails/40.jpg)
CD133• A.K.A. Prominin,
AC133• Human - 4p16.2-p12• Location: Stem and
Progenitor Cells, photoreceptor cells
(Figure from Corbeil et al. Traffic 2001 2: 82–91)
• Wider expression in embryonic tissues
• Preference for plasma membrane protrusions